PRLD: Losses increased but cash reserves strengthened; commercial launch of Psyros platform advances

About this update from Prolight Diagnostics Ab

Transitioned to commercial focus with key milestones for the Psyros POC platform, including design freeze and strong patent progress. Losses widened to -53,080 KSEK, but cash position improved after a successful rights issue. Additional financing is needed by Q3 2026.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Prolight Diagnostics Ab